Classic reference has been completely revised and updated by a renowned team of editors to produce the most current, comprehensive, and authoritative book available on treating liver cancer.

Second author, Yuman Fong, is with Memorial Sloan-Kettering Cancer Center, New York City. Text provides the latest information on traditional and cutting-edge surgical approaches, new and emerging drugs, and radiation therapy for the treatment of liver cancer. Includes more than 200 photographs and line drawings.

Everyone in America needs to read this book!! Anyone in America that has a liver problem, from Hepatitis C to liver cancer can get get better from taking this product. We have been to Dr. Berkson's office, and he is a marvelous Dr.!! You should have some kind of review to let people know about this book.

Univ. of Texas M.D. Anderson Cancer Center, Houston. Provides the general surgeon, surgical oncologist, radiation oncologist, and medical oncologist with current information regarding diagnosis and multimodality treatment approaches for patients with primary or metastatic hepatobiliary cancer. DNLM: Liver Neoplasms--diagnosis.

(Arnold) Univ. of Newcastle, New South Wales, Australia. Discusses surgical resection and new advances in etiology, pathogenesis, diagnostic and investigative procedures, and chemotherapy and non-surgical management. Presents the experience of a team at the Chinese University of Hong Kong at the Prince of Wales Hospital. For researchers and clinicians. Expanded-outline format.

Liver-Directed Therapy for Primary and Metastatic Liver Tumors is a comprehensive examination of tumors of the liver. It provides a unique multi-modality approach to management of all types of primary and secondary liver tumors. The biology of liver cancers, state of the art radiologic imaging and novel, non-surgical interventional strategies are given. There is an in depth analysis of surgical options including transplantation, resection, interstitial ablation techniques and liver-directed chemotherapy for hepatocellular carcinoma, bile duct cancers, and colorectal and neuroendocrine liver metastases. Because of the unique and comprehensive examination of liver tumors, this work is an excellent resource for surgical, transplant and medical oncologists, surgeons, gastroenterologists, and radiologists.

Northwestern Univ., Chicago, IL. Examines tumors of the liver. Covers surgical techniques; novel and evolving treatments including transplantation; radiologic staging of liver tumors; and incidence, etiology, and biologic characteristics of primary and secondary liver tumors. For specialists, surgeons, and interventionists.

The liver is the largest organ in the body and plays a vital role in regulating life processes. Each year more than 25 million Americans are afflicted with liver and gall bladder diseases, and more than 27,000 die of cirrhosis. Experts believe that more than half of all liver diseases could be prevented.

Liver Disorders Sourcebook contains basic consumer health information about the liver, how it works, and how to keep it healthy through diet, vaccination, and other preventive care measures. Readers will learn about the symptoms and treatment options for such diseases as hepatitis, primary biliary cirrhosis, Wilson's disease, hemochromatosis, liver failure, cancer of the liver, and disorders related to drugs and other toxins. Also included are a glossary and directories of support groups and additional resources.

Cancer is one of the major health problems of our time and liver cancer is responsible for over one million deaths per year world-wide, making it the fourth most common cause of death from cancer. Surgical resection of the tumour(s) is the treatment of choice and offers the only chance of prolonged survival. Yet the best attempts are often frustrated by either advanced or co-existent disease that renders the patient non-resectable. This book tackles the many options available to doctors and patients in an attempt to combat this desperate disease.

Liver Metastasis: Biology, Diagnosis and Treatment offers a comprehensive overview of liver metastasis by providing a collection of pivotal contributions from an international faculty. A wide range of topics are presented, with each contributor focusing on his own area of expertise to provide the latest techniques as well as valuable insights based on a wealth of experience. Epidemiological and biological aspects are discussed, diagnostic and staging problems are reported, and all treatment modalities are analysed including gene therapy, immunotherapy and palliative care. The standard approaches to diagnosis and therapy are examined whilst new and future trends are reported on and explored. Of interest to both specialists and postgraduates in the fields of oncology and gastroenterology this book will also be of interest to researchers in internal medicine.

Univ. of Edinburgh, UK. Offers a comprehensive overview of liver metastases. Covers biology and etiology, staging and prognosis, diagnosis, surgical and medical treatment, gene therapy, and palliative care. For practitioners in oncology and gastroenterology, and researchers in internal medicine. Extensive references. DNLM: Liver Neoplasms--secondary.

This volume informs about different techniques of isolated liver perfusion already used in clinical practice. Indications for liver perfusion are discussed from pathological, oncological and surgical viewpoints. Special aspects of anesthesia and postoperative management in the intensive care unit are explained. The pathophysiology of hyperthermia, chemotherapeutics and tumor necrosis factor in isolated liver perfusion are described. First clinical results including the use of tumor necrosis factor in combination with melphalan are reported. The radiological methods of postoperative monitoring of tumor necrosis after therapy are presented.

Memorial Sloan-Kettering Cancer Center, New York, NY. Atlas provides a brief and current summary of the status of the field. For the general surgeon, surgical oncologist, hepatologist, and radiation oncologist. Addresses the understanding and management of hepatobiliary cancer. Includes more than 200 color illustrations with all images contained on the CD-ROM. Extensive references.

Hepatocellular carcinoma (HCC) is one of the most important complications of chronic viral hepatitis. It usually results in a fatal outcome if not discovered in its earliest stages. Its close association with the hepatitis B and C viruses makes it one of the first human cancers for which there is strong evidence of a viral cause. For this reason it provides a model for studying viral carcinogenesis in humans.

In some countries, HCC is one of the most common tumors of adult men. In addition, there is evidence that the incidence of this cancer has doubled in the past 15 to 20 years in many countries, and the incidence has doubled every 20 years for the past half century in Japan. In some studies, the increase has been shown to be due primarily to cases associated with HCV infection.

Molecular studies of HCC show that mutations in oncogenes, in various cellular repair pathways, and in tumor suppressor genes together appear to contribute to the development of this cancer. In HCCs associated with hepatitis B virus, the virus itself can interact with tumor suppressor proteins and other cellular signals in ways that probably permit HCC to develop even when there are no mutations in the genes for these signals.

This work discusses the latest concepts in molecular biology and the study of HCC which have led to dramatic breakthroughs in our understanding of how it develops.

Since the early 1970s the clinical observation that a substantial percentage of patients with hepatocellular carcinoma (HCC), particularly those with chronic HBV infection, have elevated serum levels of alpha-fetoprotein (AFP), has led to the implementation of screening programs to identify early resectable lesions.

This book covers all aspects of gastrointestinal and liver malignancies (epidemiology, pathophysiology, screening where appropriate, symptoms and clinical signs, diagnostic studies, staging and classification, treatment, prognosis, follow-up, future perspectives). It is addressed to those involved in the multidisciplinary approach to the gastrointestinal cancer patient (gastroenterologists, medical oncologists, radiation therapists, surgeons, interventional radiologists, pathologists, nurses, and physicians-in-training). The book provides in-depth information, illustrated by numerous color/black-and-white pictures. Selective reading for a quick reference is made possible by introducing text elements such as summaries, tables, listing and treatment algorithms.